Ultragenyx Pharmaceutical Inc. buy SVB Leerink LLC
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€59.44
Performance (%)
24.12%
Price
17.04.26
€20.66
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC currently has a performance of 24.12%. This prediction currently runs until 30.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.873% | 4.873% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Leerink Partners from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat